The pharmaceutical industry has already been under immense pressure to reduce drug development timelines and related costs long before the pandemic. However, with the rise of the Covid-19 pandemic, challenges have gotten even more difficult for the industry. That’s why many medicine developers are choosing to manufacture and package oral solid dose (OSD) with the help of contract manufacturing organizations (CMOs).
What Makes CMOs for OSD Manufacturing and Packaging a Cost-effective Choice?
Many drug development challenges, like the more complex nature of new molecules and their bioavailability, formulation, stability, manufacturability, and scalability make the production of OSDs even more complicated. CMOs not only brings expertise in manufacturing of OSDs but also offers the advantages of access to advanced technology, state-of-the-art manufacturing facility, formulation ideas, and processing innovations to pharmaceutical companies.
However, in general, pharmaceutical companies outsource their OSD manufacturing and packaging projects to two different contract manufacturing organizations. It is because most CMOs handle either OSD manufacturing or OSD packaging but not both. While this is a viable solution to get the manufacturing and packaging of OSD products done cost-effectively, outsourcing these operations to two different CMOs has its own drawbacks.
Why collaborating with two CMOs for OSD manufacturing and packaging is not the best solution?
Understandably, working with CMOs to manufacture and package your OSD products sounds like a good solution as you get the benefit of their expertise and cutting-edge technology they are equipped with at a fraction of the cost. But, connecting with two different CMOs also means you will need two different partners for management and two different supply chains.
In addition, the drug manufacturing company is required to mediate product transfer to another CMO. This, in turn, only adds to the time and cost of bringing OSD products to the market.
The best solution to eliminate the need for two managing partners and different supply chains and reduce the cost and time of supplying the market with desired OSD products is to seek a contract manufacturing company that offers both - manufacturing and packaging solutions for OSD products.
Is there any CMO that offers manufacturing and packaging solutions for OSD in one place?
Yes. Undeniably, the complexity of the supply chain and associated issues has been brought into the brighter spotlight by the pandemic. The best way for pharmaceutical companies to weather this public health crisis is to integrate their supply chains to at least some degree.
Working with a single CMO that complies with GMP requirements for both manufacturing and packaging of OSDs at a single site is the best solution for drug companies to streamline their operations and optimize their resources for each project. It will help drug and pharmaceutical companies to get their OSD products faster to the market and ultimately to patients in need at more affordable rates.
Avara Pharmaceutical Services is an esteemed CMO based in Norman, Oklahama where manufacturing and packaging of oral solid dose (OSD) drug products are done under the management of one integrated team. The company’s Chairman and Director, “Leonard Levie” aims to tackle the current challenges and better prepare for a better future. The same vision he likes to imbibe in the culture of the companies he is a key part of.
Consequently, Avara, supported by a strong safety, health, and environmental system along with Lean Six Sigma methodologies, brings a wealth of expertise and industry knowledge in various operations such as supply chain, commercialization, and technical transfer for faster and affordable production of advanced medicines.
This means collaborating with Avara enables pharma companies around the world to overcome their challenges and address the patients’ medical needs while reducing the overall cost.
No comments:
Post a Comment